CR3 IN CELL ACTIVATION AND PHAGOCYTOSIS OF GONORRHEA
Project Number5K08AI001476-02
Contact PI/Project LeaderINGALLS, ROBIN R
Awardee OrganizationBOSTON MEDICAL CENTER
Description
Abstract Text
Neisseria gonorrhoeae (GC) is one of the most common sexually
transmitted pathogens in the United States, Infection with GC
usually remains localized to the lower genital tract, although
certain strains are capable of dissemination. During infection of
the urogenital tract with GC, bacteria encounter macrophages in
the endometrium and other tissues. Here, surface antigens on the
gonococcus trigger the local and systemic humoral immune
response that results in the release of cytokines, prostaglandin, and
other inflammatory mediators. Although previous efforts have
focused on defining immunologic responses to protein antigens,
studies would suggest that when phagocytes encounter Gram-
negative bacteria, the subsequent cytokine response is due to the
interactions of bacterial lipopolysaccharides (LPS) with
macrophage receptors. In addition, the activation and fixation of
complement by GC plays a major role in bacterial interactions
with both professional and non-professional phagocytes. The goal
of this proposal is to analyze the nature of the interaction between
GC and the mammalian receptors likely to be activated in
response to bacterial invasion. Efforts to characterize mammalian
receptors for GC will focus on the leukocyte CD11/CD18
integrins. This family of adhesion receptors includes CD11b/CD18
(CR3) and CD11c/CD18 (CR4) which are phagocytic receptors
for iC3b and opsonized bacteria, as well as signaling receptors for
LPS. The focus of this proposal is to identify the molecular
mechanisms involved in phagocytosis and LPS signal transduction
using CR3- and CR4-transfected fibroblast cell lines. Because
native phagocytes express multiple binding proteins on their
surface, they have not been a useful tool for the study of a single
receptor class. Furthermore, unlike monocytic lines, transfected
fibroblast lines can be genetically manipulated in order to identify
genes involved in phagocytosis and LPS signaling. Four Specific
Aim are proposed. First, we will define the individual roles of
the complement receptors CR3 and CR4 in phagocytosis and cell
activation by GC and gonococcal LOS. The role of the
complement receptors will be compared to that of CD14, a well-
characterized LPS receptor on macrophages. Second, using
differential display we will identify and characterize phagocytosis
inducible genes from established wild type (phagocytosing) and
cytoplasmic deletion mutant (non-phagocytosing) CR3-transfected
CHO line. Finally, we will use somatic cell mutagenesis
techniques to generate phagocytosis mutants in the CR3-
transfected CHO line. Complementation analysis can then be used
to identify genes essential for phagocytosis in human monocytes.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
CD antigensCHO cellsNeisseria gonorrhoeaeantiserumbiological signal transductioncomplement receptorgene deletion mutationhamstershuman tissueintegrinslaboratory mouselaboratory rabbitleukocyte activation /transformationlipopolysaccharidesmolecular cloningphagocytosisreceptor bindingreceptor expressionsite directed mutagenesistransfection
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
005492160
UEI
JZ8RQC4EMDZ5
Project Start Date
01-August-1997
Project End Date
31-July-2002
Budget Start Date
01-August-1998
Budget End Date
31-July-1999
Project Funding Information for 1998
Total Funding
$77,652
Direct Costs
$71,900
Indirect Costs
$5,752
Year
Funding IC
FY Total Cost by IC
1998
National Institute of Allergy and Infectious Diseases
$77,652
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K08AI001476-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K08AI001476-02
Patents
No Patents information available for 5K08AI001476-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K08AI001476-02
Clinical Studies
No Clinical Studies information available for 5K08AI001476-02
News and More
Related News Releases
No news release information available for 5K08AI001476-02
History
No Historical information available for 5K08AI001476-02
Similar Projects
No Similar Projects information available for 5K08AI001476-02